Form EFFECT SpyGlass Pharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:05 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMedNewsBreaks — MindBio Therapeutics Corp.’s (CSE: MBIO) (OTCQB: MBQIF) Edge AI Kiosks Target Rapid, Scalable Impairment Screening
- Troutman Amin, LLP Partner Brittany Andres Speaks at Affiliate Summit East–The Premier Performance Marketing Event on the East Coast
- Hop-on Introduces Digitalage Live Pass, Targeting First Paid Premium Broadcasts in August 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
